Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 19/20 | 0.47 |
| ▸ | TDO2 | P48775 | 7/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.47 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.47 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.43 |
| ▸ | CDK9 | P50750 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21034703 | 0.87 | IDO1 (0.58) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL29923819 | 0.87 | IDO1 (0.58) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL22270527 | 0.81 | IDO1 (0.49) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL22387529 | 0.81 | IDO1 (0.49) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL23699136 | 0.81 | IDO1 (0.48) | IDO1CCNT1CDK9 | |
| SCHEMBL21384588 | 0.80 | IDO1 (0.48) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL21061136 | 0.80 | IDO1 (0.62) | IDO1TDO2CYP2C9CYP2C8CCNT1 | |
| SCHEMBL22635748 | 0.80 | IDO1 (0.61) | IDO1TDO2CYP2C9CYP2C8CCNT1 | |
| SCHEMBL21289790 | 0.80 | IDO1 (0.58) | IDO1TDO2CYP2C9CYP2C8CYP3A4 | |
| SCHEMBL23699112 | 0.79 | IDO1 (0.57) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3753926-B1 | SPIRO COMPOUND AS INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR | SHANGHAI INST ORGANIC CHEMISTRY CAS (CN) | 2024-10-09 | — | — | EP | disclosed |
| US-20210047290-A1 | SPIRO COMPOUND AS INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2021-02-18 | — | — | US | disclosed |
| US-20210047290-A1 | SPIRO COMPOUND AS INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2021-02-18 | — | — | US | disclosed |
| EP-3753926-A1 | SPIRO COMPOUND AS INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2020-12-23 | — | — | EP | disclosed |
| WO-2019158051-A1 | SPIRO COMPOUND AS INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR | 中国科学院上海有机化学研究所 | 2019-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047290-A1 | SPIRO COMPOUND AS INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR | IDO1, IDO2, TPH1 | IDO1 1/4885TDO2 5/4885CYP2C9 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.